For help on how to get the results you want, see our search tips.
209 results
-
List item
Referral: Cozaar Comp
losartan + hydrochlorothiazide, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/04/2008, EC decision date: 03/09/2008, Last updated: 25/09/2008 -
List item
Referral: Actilyse
Alteplase, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2002, EC decision date: 30/09/2002, Last updated: 25/01/2006 -
List item
Referral: Adartrel
Ropinirole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 15/09/2005, EC decision date: 03/04/2006, Last updated: 21/04/2006 -
List item
Referral: Aggrastat
Tirofiban, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/03/1999, EC decision date: 18/06/1999, Last updated: 18/06/1999 -
List item
Referral: Agopton
Lansoprazole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 21/09/2006, EC decision date: 13/12/2006, Last updated: 20/12/2006 -
List item
Referral: Alcover and associated names
sodium oxybate, associated names: n/a, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/01/2017, EC decision date: 18/12/2017, Last updated: 12/01/2018 -
List item
Referral: Alendronate HEXAL
alendronic acid (as sodium alendronate trihydrate), Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/01/2007, EC decision date: 13/04/2007, Last updated: 20/08/2007 -
List item
Referral: Alvesco
ciclesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2008, EC decision date: 11/07/2008, Last updated: 05/08/2008 -
List item
Referral: Amaryl
Glimepiride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 17/04/1996, EC decision date: 29/08/1996, Last updated: 03/08/1998 -
List item
Referral: Amlodipin Woerwag
Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 27/04/2004, Last updated: 30/06/2004 -
List item
Referral: Amlovita
Amlodipine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/01/2004, EC decision date: 26/04/2004, Last updated: 26/04/2004 -
List item
Referral: Amoxil
amoxicillin, Article 30 referrals
Status: European Commission final decision, opinion/position date: 25/06/2015, EC decision date: 20/08/2015, Last updated: 19/05/2016 -
List item
Referral: Arimidex
anastrozole, Article 30 referrals
Status: European Commission final decision, opinion/position date: 17/03/2011, EC decision date: 18/05/2011, Last updated: 27/07/2011 -
List item
Referral: Atacand
candesartan, associated names: Amias, Blopress, Kenzen, Racanda, Ratacand, Parapres, Article 30 referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 13/07/2010, Last updated: 16/03/2011 -
List item
Referral: Atacand Plus
candesartan / hydrochlorothiazide, associated names: Atacand Zid, Blopresid, Blopress Comp, Blopress Plus, CoKenzen, Hytacand, Parapres Plus, Ratacand Plus, Article 30 referrals
Status: European Commission final decision, opinion/position date: 24/06/2010, EC decision date: 16/09/2010, Last updated: 21/09/2011 -
List item
Referral: Augmentin
amoxicillin and clavulanic acid, Article 30 referrals
Status: European Commission final decision, opinion/position date: 19/01/2009, EC decision date: 19/10/2009, Last updated: 18/11/2013 -
List item
Referral: Avalox
moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013 -
List item
Referral: Betavert N
betahistine dihydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/03/2009, EC decision date: 02/06/2009, Last updated: 01/07/2007 -
List item
Referral: Bicaluplex
bicalutamide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/09/2007, EC decision date: 22/11/2007, Last updated: 07/02/2008 -
List item
Referral: Bleomycin
bleomycin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2008, EC decision date: 12/03/2009, Last updated: 31/03/2009 -
List item
Referral: Budesonide Sandoz
budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009 -
List item
Referral: Budesonide SUN
budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2020, EC decision date: 19/08/2020, Last updated: 16/09/2020 -
List item
Referral: Calcichew D3
Calcium 500 mg / cholecalciferol 10 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Calcichew D3 mite
Calcium 500 mg / cholecalciferol 5 µg, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004 -
List item
Referral: Calcitugg
Calcium carbonate, Article 30 referrals
Status: European Commission final decision, opinion/position date: 26/06/2003, EC decision date: 01/12/2003, Last updated: 21/01/2004